186 related articles for article (PubMed ID: 19330330)
1. Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro.
Gervais A; Eymard JC; Toulmonde E; Bernard J
Cancer Immunol Immunother; 2009 Nov; 58(11):1831-41. PubMed ID: 19330330
[TBL] [Abstract][Full Text] [Related]
2. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
[TBL] [Abstract][Full Text] [Related]
3. Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.
Wells JW; Cowled CJ; Darling D; Guinn BA; Farzaneh F; Noble A; Galea-Lauri J
Cancer Immunol Immunother; 2007 Dec; 56(12):1861-73. PubMed ID: 17487489
[TBL] [Abstract][Full Text] [Related]
4. In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.
Santegoets SJ; Schreurs MW; Masterson AJ; Liu YP; Goletz S; Baumeister H; Kueter EW; Lougheed SM; van den Eertwegh AJ; Scheper RJ; Hooijberg E; de Gruijl TD
Cancer Immunol Immunother; 2006 Dec; 55(12):1480-90. PubMed ID: 16468034
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.
Zhang Y; Ma B; Zhou Y; Zhang M; Qiu X; Sui Y; Zhang X; Ma B; Fan Q
Breast Cancer Res Treat; 2007 Nov; 105(3):277-86. PubMed ID: 17187233
[TBL] [Abstract][Full Text] [Related]
6. The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-gamma ELISPOT assays.
Britten CM; Meyer RG; Frankenberg N; Huber C; Wölfel T
J Immunol Methods; 2004 Apr; 287(1-2):125-36. PubMed ID: 15099761
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
8. Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.
Obermann S; Petrykowska S; Manns MP; Korangy F; Greten TF
Immunology; 2007 Sep; 122(1):90-7. PubMed ID: 17472719
[TBL] [Abstract][Full Text] [Related]
9. Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL.
Cao T; Ueno H; Glaser C; Fay JW; Palucka AK; Banchereau J
Eur J Immunol; 2007 Sep; 37(9):2657-67. PubMed ID: 17683111
[TBL] [Abstract][Full Text] [Related]
10. Binding of monosodium urate crystals with idiotype protein efficiently promote dendritic cells to induce cytotoxic T cells.
Sakamaki I; Inai K; Tsutani Y; Ueda T; Tsutani H
Cancer Sci; 2008 Nov; 99(11):2268-73. PubMed ID: 19037977
[TBL] [Abstract][Full Text] [Related]
11. CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responses.
Freeman JL; Vari F; Hart DN
J Immunother; 2007 Oct; 30(7):740-8. PubMed ID: 17893566
[TBL] [Abstract][Full Text] [Related]
12. Human dendritic cells: natural adjuvants in antitumor immunotherapy.
Di Nicola M; Anichini A; Mortarini R; Bregni M; Parmiani G; Gianni AM
Cytokines Cell Mol Ther; 1998 Dec; 4(4):265-73. PubMed ID: 10068060
[TBL] [Abstract][Full Text] [Related]
13. Allo-restricted CTLs generated by coculturing of PBLs and autologous monocytes loaded with allogeneic peptide/HLA/IgG1-Fc fusion protein.
Weng X; Lu S; Zhong M; Liang Z; Shen G; Chen J; Wu X
J Leukoc Biol; 2009 Mar; 85(3):574-81. PubMed ID: 19112092
[TBL] [Abstract][Full Text] [Related]
14. Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers.
Oosten LE; Blokland E; Kester MG; Falkenburg JH; van Halteren AG; Goulmy E
Biol Blood Marrow Transplant; 2007 Feb; 13(2):151-63. PubMed ID: 17241921
[TBL] [Abstract][Full Text] [Related]
15. Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses.
Chapatte L; Ayyoub M; Morel S; Peitrequin AL; Lévy N; Servis C; Van den Eynde BJ; Valmori D; Lévy F
Cancer Res; 2006 May; 66(10):5461-8. PubMed ID: 16707475
[TBL] [Abstract][Full Text] [Related]
16. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.
Soleimani A; Berntsen A; Svane IM; Pedersen AE
Scand J Immunol; 2009 Nov; 70(5):481-9. PubMed ID: 19874553
[TBL] [Abstract][Full Text] [Related]
17. Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation.
Hoogendoorn M; Olde Wolbers J; Smit WM; Schaafsma MR; Jedema I; Barge RM; Willemze R; Falkenburg JH
Clin Cancer Res; 2005 Jul; 11(14):5310-8. PubMed ID: 16033850
[TBL] [Abstract][Full Text] [Related]
18. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
[TBL] [Abstract][Full Text] [Related]
19. Exposure to the electrofusion process can increase the immunogenicity of human cells.
Hock BD; Roberts G; McKenzie JL; Gokhale P; Salm N; McLellan AD; Patton NW; Roake JA
Cancer Immunol Immunother; 2005 Sep; 54(9):880-90. PubMed ID: 15926080
[TBL] [Abstract][Full Text] [Related]
20. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice.
Chen L; Tang XD; Yu ST; Ai ZH; Fang DC; Cai YG; Luo YH; Liang GP; Yang SM
J Pathol; 2009 Apr; 217(5):685-92. PubMed ID: 19142972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
